![]() |
Volumn 2, Issue 1, 2005, Pages 45-51
|
Comparative study of different silymarin formulations: Formulation, characterisation and in vitro/in vivo evaluation
|
Author keywords
Hepatoprotection; Lipid microspheres; Silymarin; Soya lecithin
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ASPARTATE AMINOTRANSFERASE;
COSURFACTANT;
LIPID EMULSION;
MICROSPHERE;
OIL;
PHENOBARBITAL;
PHOSPHATIDYLCHOLINE;
PHOSPHOLIPID;
POLYSORBATE 80;
PROPYLENE GLYCOL;
SILYMARIN;
SOYABEAN OIL;
UNCLASSIFIED DRUG;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ARTICLE;
ASPARTATE AMINOTRANSFERASE BLOOD LEVEL;
COMPARATIVE STUDY;
CONTROLLED STUDY;
DRUG DELIVERY SYSTEM;
DRUG EFFECT;
DRUG FORMULATION;
DRUG INHIBITION;
DRUG POTENTIATION;
DRUG RELEASE;
DRUG SCREENING;
DRUG TARGETING;
ENZYME BLOOD LEVEL;
ENZYME INHIBITION;
HISTOPATHOLOGY;
IN VITRO STUDY;
IN VIVO STUDY;
LIVER PROTECTION;
MALE;
MEMBRANE FILTER;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
SLEEP TIME;
SOYBEAN;
ADMINISTRATION, ORAL;
ALANINE TRANSAMINASE;
ANIMALS;
ANTIOXIDANTS;
ASPARTATE AMINOTRANSFERASES;
BIOLOGICAL AVAILABILITY;
CHLOROFORM;
DRUG CARRIERS;
DRUG EVALUATION, PRECLINICAL;
EMULSIONS;
HEPATITIS, TOXIC;
INJECTIONS, INTRAVENOUS;
LIVER;
MALE;
MICE;
MICROSPHERES;
PARTICLE SIZE;
PHOSPHOLIPIDS;
RATS;
RATS, WISTAR;
SILYMARIN;
SLEEP;
SOLUTIONS;
|
EID: 17844393389
PISSN: 15672018
EISSN: None
Source Type: Journal
DOI: 10.2174/1567201052772870 Document Type: Article |
Times cited : (46)
|
References (19)
|